Back to List View Graph View

Ulcerative colitis

Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by inflammation of the colonic mucosa.

Where the papers sit

10 papers from the last 6 months study ulcerative colitis directly · updated from PubMed 13 Nov 2026

Those 10 are all about one subject.

  • Emerging Colitis Treatments

    Novel anti-inflammatory agents and colon-targeted formulations are expanding treatment development beyond conventional 5-ASA delivery. MKK3 modulation, TNF-α suppression, duvakitug, and peptide or plant-derived therapies recur, with mucosal healing and efficacy as key endpoints. Nanovesicles, nanocubosomes, and long-acting formulations aim to improve local exposure and therapeutic effect. Biomarker studies and trial-design work support more innovative development, but clinical validation remains uneven.

    10 papers

NEW DIRECTION

Ulcerative colitis is framed as a ferro-aging state rather than only an inflammatory disease

The study of ferro-aging-related biomarkers in ulcerative colitis identifies an ACSL4-associated, iron-dependent aging-related state that is increased in active disease and linked to inflammation, oxidative stress, epithelial injury, immune infiltration, and tissue remodeling 42667131Aug. This gives ulcerative colitis a new biological role in the set: not merely a disease target, experimental colitis model, or source of diagnostic signatures, but a disease stratified by a ferro-aging state that may organize its molecular heterogeneity and clinical activity.

Papers

The 10 papers from the last 6 months that study ulcerative colitis directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

Emerging Colitis Treatments (10)
  1. Design and Synthesis of Novel, Non-ATP-Competitive MKK3 Modulators as Suppressors of TNF-α Production for the Treatment of Ulcerative Colitis. Journal of medicinal chemistry · 12 Nov 2026 PMID 43018599
  2. Grapefruit-derived nanovesicles: a promising nanoplatform for enhancing the therapeutic efficacy of andrographolide against ulcerative colitis. Bioorganic chemistry · 1 Oct 2026 PMID 42822355
  3. Identification of Ferro-Aging-Related Biomarkers for Ulcerative Colitis Through Integrated Machine Learning, Single-Cell Analysis, and Spatial Transcriptomics. FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 29 Aug 2026 PMID 42667131
  4. Linoleic acid-based pH-sensitive 5-ASA nanocubosome pellets for colon targeting in ulcerative colitis: in vitro and in vivo comparison with non-pH-sensitive and conventional formulations. Drug development and industrial pharmacy · 12 Aug 2026 PMID 42585548
  5. Green and efficient ultrasound-assisted extraction of Banqiao Codonopsis Radix polysaccharides: Process optimization, extraction mechanism, and in vivo anti-ulcerative colitis efficacy with mechanistic insight. Ultrasonics sonochemistry · 3 Aug 2026 PMID 42546441
  6. Efficacy and safety of duvakitug in patients with ulcerative colitis (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial. The lancet. Gastroenterology & hepatology · 16 Jul 2026 PMID 42462750
  7. Entering a new age of innovation in IBD clinical trial design. Med (New York, N.Y.) · 12 Jun 2026 PMID 42285045
  8. Discovery of self-assembled nanoparticles from Rubia cordifolia L. before and after carbonization and mechanistic study on their targeted therapy for ulcerative colitis. Phytomedicine : international journal of phytotherapy and phytopharmacology · 10 Jun 2026 PMID 42269185
  9. Chishizhi Yuyuliang Decoction Ameliorates Ulcerative Colitis in Mice by Promoting Colonic Epithelial Mucosal Healing via the CAV1/FA Axis. Rapid communications in mass spectrometry : RCM · 27 May 2026 PMID 42200545
  10. A novel peptide from Periplaneta americana: Development of a long-acting formulation for ulcerative colitis therapy. Biomaterials advances · 23 May 2026 PMID 42176559

By study type

Clinical trials (1)
  1. Efficacy and safety of duvakitug in patients with ulcerative colitis (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial. The lancet. Gastroenterology & hepatology · 16 Jul 2026 PMID 42462750
Human data, design not indexed (2)
  1. Identification of Ferro-Aging-Related Biomarkers for Ulcerative Colitis Through Integrated Machine Learning, Single-Cell Analysis, and Spatial Transcriptomics. FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 29 Aug 2026 PMID 42667131
  2. Entering a new age of innovation in IBD clinical trial design. Med (New York, N.Y.) · 12 Jun 2026 PMID 42285045
Preclinical: animal, cell and lab studies (7)
  1. Design and Synthesis of Novel, Non-ATP-Competitive MKK3 Modulators as Suppressors of TNF-α Production for the Treatment of Ulcerative Colitis. Journal of medicinal chemistry · 12 Nov 2026 PMID 43018599
  2. Grapefruit-derived nanovesicles: a promising nanoplatform for enhancing the therapeutic efficacy of andrographolide against ulcerative colitis. Bioorganic chemistry · 1 Oct 2026 PMID 42822355
  3. Linoleic acid-based pH-sensitive 5-ASA nanocubosome pellets for colon targeting in ulcerative colitis: in vitro and in vivo comparison with non-pH-sensitive and conventional formulations. Drug development and industrial pharmacy · 12 Aug 2026 PMID 42585548
  4. Green and efficient ultrasound-assisted extraction of Banqiao Codonopsis Radix polysaccharides: Process optimization, extraction mechanism, and in vivo anti-ulcerative colitis efficacy with mechanistic insight. Ultrasonics sonochemistry · 3 Aug 2026 PMID 42546441
  5. Discovery of self-assembled nanoparticles from Rubia cordifolia L. before and after carbonization and mechanistic study on their targeted therapy for ulcerative colitis. Phytomedicine : international journal of phytotherapy and phytopharmacology · 10 Jun 2026 PMID 42269185
  6. Chishizhi Yuyuliang Decoction Ameliorates Ulcerative Colitis in Mice by Promoting Colonic Epithelial Mucosal Healing via the CAV1/FA Axis. Rapid communications in mass spectrometry : RCM · 27 May 2026 PMID 42200545
  7. A novel peptide from Periplaneta americana: Development of a long-acting formulation for ulcerative colitis therapy. Biomaterials advances · 23 May 2026 PMID 42176559